Organization | Franklin Square Hospital Center

Franklin Square Hospital Center Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial

1996

NCT00002819

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

1999

Timeline

NOW

Alternative names

Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center | Harry & Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center

Active Ingredients

Drugs in Phase 3 Trials (6)

autologous hematopoietic stem cells (1 trial)

bone autograft (1 trial)

carboplatin (paraplatin) (1 trial)

cyclophosphamide (cytoxan) (2 trials)

mitoxantrone (novantrone) (1 trial)

paclitaxel (taxol) (1 trial)

Drugs in Phase 2 Trials (6)

doxorubicin (Doxil) (1 trial)

etoposide (vepesid) (1 trial)

prednisone (meticorten) (1 trial)

rituximab (rituxan) (1 trial)

sargramostim (leukine) (1 trial)

vincristine (oncovin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Carcinoma, Ovarian Epithelial (Phase 3)

Lymphoma (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Ovarian Neoplasms (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 2
# of Trial APIs: 12